Macrogen, Inc. (KOSDAQ:038290)

South Korea flag South Korea · Delayed Price · Currency is KRW
16,440
-460 (-2.72%)
Apr 29, 2026, 3:30 PM KST
2.18%
Market Cap 183.22B
Revenue (ttm) 195.27B
Net Income (ttm) 2.03B
Shares Out 10.84M
EPS (ttm) 187.00
PE Ratio 90.37
Forward PE 16.44
Dividend 300.00 (1.76%)
Ex-Dividend Date Dec 29, 2025
Volume 69,062
Average Volume 31,139
Open 16,870
Previous Close 16,900
Day's Range 16,060 - 16,870
52-Week Range 14,720 - 20,900
Beta 0.73
RSI 46.83
Earnings Date May 15, 2026

About Macrogen

Macrogen, Inc. provides precision medicine and bio-engineering healthcare services in Korea and internationally. It offers personal healthcare services, including disease prediction and wellness genetic, and DTC genetic testing services; MyPETGENE, a genetic testing service for companion animals; clinical services, such as precision medicine, genetic testing for cancer risk, NGS-based genetic panel lab, and GCLP services; and single cell expert services comprising single cell multi-omics and spatial transcriptome analysis, and single cell (In S... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1997
Employees 475
Stock Exchange KOSDAQ
Ticker Symbol 038290
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.